STK11 and neoplasm: With the deepening of immunometabolic studies, it has been shown that PI3K/Akt/mTOR and LKB1-AMPK, as core immunometabolic signaling pathways, can largely influence tumor progression in the continuous crosstalk between immune and metabolic signals [38].